These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 12713553)

  • 1. Topical rapamycin (sirolimus) for the treatment of facial discoid dermatosis.
    Huang YW; Tsai TF
    Eur J Dermatol; 2024 Apr; 34(2):201-203. PubMed ID: 38907553
    [No Abstract]   [Full Text] [Related]  

  • 2. An analysis of inter- and intra-rater Facial Vitiligo Area Scoring Index assessments in adults with active nonsegmental vitiligo.
    Banerjee A; Ezzedine K; Shore R; Peeva E; Yamaguchi Y; Cox L; Sloan A; Gamalo M; Reyes CR
    Br J Dermatol; 2024 Aug; 191(3):453-454. PubMed ID: 37936303
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of treatment response on facial vitiligo, a step forward. But what about the neck?
    Eleftheriadou V; Seneschal J
    Br J Dermatol; 2023 Dec; 190(1):5-6. PubMed ID: 37751397
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditions.
    Simpson D; Noble S
    Drugs; 2005; 65(6):827-58. PubMed ID: 15819596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New treatment modalities for vitiligo: focus on topical immunomodulators.
    Kostovic K; Pasic A
    Drugs; 2005; 65(4):447-59. PubMed ID: 15733009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical macrolide immunomodulators: a role in the treatment of vitiligo?
    Tjioe M; Vissers WH; Gerritsen MJ
    Am J Clin Dermatol; 2006; 7(1):7-12. PubMed ID: 16489839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo.
    Mehrabi D; Pandya AG
    Arch Dermatol; 2006 Jul; 142(7):927-9. PubMed ID: 16847214
    [No Abstract]   [Full Text] [Related]  

  • 8. Vitiligo treatment with monochromatic excimer light and tacrolimus: results of an open randomized controlled study.
    Nisticò S; Chiricozzi A; Saraceno R; Schipani C; Chimenti S
    Photomed Laser Surg; 2012 Jan; 30(1):26-30. PubMed ID: 22054204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repigmentation of vitiligo with pimecrolimus cream: a case report.
    Mayoral FA; Gonzalez C; Shah NS; Arciniegas C
    Dermatology; 2003; 207(3):322-3. PubMed ID: 14571079
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitiligo: a potential autoimmune sequela of DRESS syndrome.
    Lonowski S; Hau J; Worswick S
    Br J Dermatol; 2016 Sep; 175(3):642-4. PubMed ID: 27038429
    [No Abstract]   [Full Text] [Related]  

  • 11. Repigmentation of chronic vitiligo lesions by following tacrolimus plus ultraviolet-B-narrow-band.
    Castanedo-Cazares JP; Lepe V; Moncada B
    Photodermatol Photoimmunol Photomed; 2003 Feb; 19(1):35-6. PubMed ID: 12713553
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
    Li R; Qiao M; Wang X; Zhao X; Sun Q
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.